SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Atara Biotherapeutics, Inc. (ATRA) News

Track canonical SquawkNews coverage tagged to ATRA, Atara Biotherapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ATRA Asset equity Sector Markets 90 days 1 Last 9.56 Updated Sep 04, 2026, 10:32 PM UTC Open live news feed
L Atara director Brian N. Cherry buys $999,993 in common stock Atara Biotherapeutics director Brian N. Cherry purchased 104,166 shares of common stock at $9.60 per share for $999,993. He directly owns 166,486 shares after the transaction. EQUITY | Sep 04, 2026, 10:32 PM UTC